- Good men should not be quiet spectators
- We will continue to work with refugee-hosting countries to find solutions
- Voting underway for Gazipur City Corporation elections
- SC upholds Khaleda’s bail in Cumilla arson case
- Teesta inundates 10 Nilphamari villages
- AL confident of victory, fair balloting in Gazipur
- Nahid urges all to work for improving quality of education
- Looting going on in banking sector: Menon
- PM for BD-India sharing of expertise in coastal security
- Ronaldo misses penalty, Portugal draws 1-1 with Iran
Maria Sharapova suspended for 2 years for doping
Maria Sharapova was suspended from tennis for two years Wednesday for testing positive for meldonium at the Australian Open, and immediately responded by saying she would appeal the decision to sport's highest court.
The ruling by an independent three-person panel appointed by the International Tennis Federation said Sharapova did not intend to cheat because she didn't know meldonium was banned, but that she bore "sole responsibility" and "very significant fault" for the positive test.
"While the tribunal concluded correctly that I did not intentionally violate the anti-doping rules, I cannot accept an unfairly harsh two-year suspension," Sharapova said in a statement. "The tribunal, whose members were selected by the ITF, agreed that I did not do anything intentionally wrong, yet they seek to keep me from playing tennis for two years. I will immediately appeal the suspension portion of this ruling to CAS, the Court of Arbitration for Sport."
The five-time Grand Slam champion was provisionally suspended by the ITF in early March, when she announced at a news conference in Los Angeles that she failed a doping test in January.
Sharapova said then she was not aware that the World Anti-Doping Agency had barred athletes from using meldonium, also known as mildronate, as of Jan. 1.
Her lawyer, John Haggerty, said Sharapova took the substance after that date.
Lawyers representing the ITF argued their side, while Haggerty argued hers. He said she spoke at the hearing.
"This was a deliberate decision, not a mistake," the ITF said. "Taken together with the evidence that over a period of three years she did not disclose her use of mildronate to her coach, trainer, physio, nutritionist or any medical adviser she consulted through the WTA, the facts are only consistent with a deliberate decision to keep secret from the anti-doping authorities the fact that she was using mildronate in competition."
In addition to testing positive at the Australian Open, the ITF said she also failed a test for meldonium in an out-of-competition control in Moscow on Feb. 2.
Sharapova's ban is due to end on Jan. 25, 2018.
The World Anti-Doping Agency said it would review the decision and decide whether or not to lodge its own appeal to CAS. WADA has the right to appeal if it feels a sanction is too lenient or too strong.
Sharapova said she first was prescribed the Latvian-made drug, typically used for heart conditions, for medical reasons in 2006. She could have been barred from competing for up to four years.
"Today with their decision of a two-year suspension, the ITF tribunal unanimously concluded that what I did was not intentional," Sharapova said. "The tribunal found that I did not seek treatment from my doctor for the purpose of obtaining a performance enhancing substance.
"The ITF spent tremendous amounts of time and resources trying to prove I intentionally violated the anti-doping rules and the tribunal concluded I did not."
The ban throws into doubt the on-court future of Sharapova, a 29-year-old Russian who is one of the most well-known and — thanks to a wide array of endorsements — highest-earning athletes in the world.
She is a former top-ranked player who is one of 10 women in tennis history with a career Grand Slam — at least one title from each of the sport's four most important tournaments. So much came so easily for her at the start: Wimbledon champion in 2004 at age 17; No. 1 in the rankings at 18; U.S. Open champion at 19; Australian Open champion at 20.
An operation to her right shoulder in 2008 took her off the tour for months, and her ranking dropped outside the top 100. But she worked her way back, and in 2012, won the French Open, then added a second title in Paris two years later.
Sharapova hasn't played since a quarterfinal loss to Serena Williams at this year's Australian Open, and she is ranked 26th this week.
Sharapova and the Russian team had hoped she would be cleared in time to compete at the Olympics in Rio de Janeiro in August, but after the ruling Russian Tennis Federation president Shamil Tarpishchev told the Tass news agency that Ekaterina Makarova would replace her.